Journal of Biological Chemistry
Volume 276, Issue 44, 2 November 2001, Pages 41270-41278
Journal home page for Journal of Biological Chemistry

PROTEIN STRUCTURE AND FOLDING
Transmembrane Topology of the Sulfonylurea Receptor SUR1*

https://doi.org/10.1074/jbc.M106555200Get rights and content
Under a Creative Commons license
open access

Sulfonylurea receptors (SURx) are multi-spanning transmembrane proteins of the ATP-binding cassette (ABC) family, which associate with Kir6.x to form ATP-sensitive potassium channels. Two models, with 13–17 transmembrane segments, have been proposed for SURx topologies. Recently, we demonstrated that the amino-terminal region of SUR1 contains 5 transmembrane segments, supporting the 17-transmembrane model. To investigate the topology of the complete full-length SUR1, two strategies were employed. Topology was probed by accessibility of introduced cysteines to a membrane-impermeable biotinylating reagent, biotin maleimide. Amino acid positions 6/26, 99, 159, 337, 567, 1051, and 1274 were accessible, therefore extracellular, whereas many endogenous and some introduced cysteines were inaccessible, thus likely cytoplasmic or intramembrane. These sites correspond to extracellular loops 1–3, 5–6, and 8 and the NH2 terminus, and intracellular loops 3–8 and COOH terminus in the 17-transmembrane model. Immunofluorescence was used to determine accessibility of epitope-tagged SUR1 in intact and permeabilized cells. Epitopes at positions 337 and 1050 (putative external loops 3 and 6) were labeled in intact cells, therefore external, whereas positions 485 and 1119 (putative internal loops 5 and 7) only were accessible after permeabilization and therefore internal. These results are compatible with the 17-transmembrane model with two pairs of transmembrane segments as possible reentrant loops.

Cited by (0)

Published, JBC Papers in Press, August 23, 2001, DOI 10.1074/jbc.M106555200

*

This work was supported by an American Heart Association Western Affiliate grant-in-aid (to C. A. V.), National Institutes of Health Grant HL 41656 (to C. A. V.), National Institutes of Health Grant DK 57699 (to S.-L. S.), and a grant from the March of Dimes Birth Defects Foundation (to S.-L. S.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.